Quote | PetVivo Holdings Inc. Warrant (NASDAQ:PETVW)
Last: | $0.0992 |
---|---|
Change Percent: | -0.81% |
Open: | $0.1 |
Close: | $0.0992 |
High: | $0.105 |
Low: | $0.089 |
Volume: | 16,175 |
Last Trade Date Time: | 04/08/2024 03:00:00 am |
News | PetVivo Holdings Inc. Warrant (NASDAQ:PETVW)
MINNEAPOLIS, MN, US, June 28, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, reported results for the fiscal year ended March 31, 2024. All comparisons are to t...
MINNEAPOLIS, MN, US, June 25, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, will hold a conference call on Friday, June 28, 2024 at 5:00 p.m. Eastern time to d...
Message Board Posts | PetVivo Holdings Inc. Warrant (NASDAQ:PETVW)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
PetVivo Holdings Inc. Warrant Company Name:
PETVW Stock Symbol:
NASDAQ Market:
PetVivo Holdings Inc. Warrant Website:
MINNEAPOLIS, MN, US, June 28, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, reported results for the fiscal year ended March 31, 2024. All comparisons are to t...
MINNEAPOLIS, MN, US, June 25, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, will hold a conference call on Friday, June 28, 2024 at 5:00 p.m. Eastern time to d...
MINNEAPOLIS, MN, US, June 06, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, has appointed Bryan Monninger to vice president of sales. In this new...